Neurological Disorders Clinical Trial
— SWADAPT1Official title:
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving of Patients With Neurological Disorders, Regular Drivers of Electric Wheelchairs.
Verified date | November 2019 |
Source | Pôle Saint Hélier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.
Status | Completed |
Enrollment | 25 |
Est. completion date | June 18, 2019 |
Est. primary completion date | June 18, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Aged over 18, - Having freely consented to participate in the study, - suffering from neurological disorders such as cerebro-lesion or neuro-degeneration, - Having benefited from a prescription of electric wheelchair and circulating in an electric wheelchair for more than 3 months, - of which the electric wheelchair is the main mode of transport, - The physical measurements (weight, height) are compatible with the use of the electric wheelchair chosen for the development of the robotics assistance module. Exclusion Criteria: - Understanding difficulties preventing the realization of the protocol, - Motor disorders of the upper limb requiring additional driving technical assistance, - Patient having expressed difficulties impacting his safety of sedan and / or exterior. |
Country | Name | City | State |
---|---|---|---|
France | Pôle Saint-Hélier | Rennes | Bretagne |
Lead Sponsor | Collaborator |
---|---|
Pôle Saint Hélier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of collision | The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. | Day 1 | |
Primary | Number of collision | The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. | Day 8 | |
Primary | Number of collision | The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. | Day 15 | |
Secondary | Driving Speed | Speed measured by the completion time of the course with and without activation of the assistance system on the different circuits | Day 1, Day 8 and Day 15 | |
Secondary | Wheelchair Skill Test | Driving performance measured by the Wheelchair Skill Test items corresponding to the different courses, with and without activation of the assistance system | Day 1, Day 8 and Day 15 | |
Secondary | NASA-Task Load Index | The cognitive load of tests under both conditions will be measured by the NASA-Task Load Index. It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity. Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance) | Day 1, Day 8 and Day 15 | |
Secondary | Ease of Use Questionnaire | The satisfaction of the use of the electric wheelchair under the conditions will be evaluated by the self-questionnaire Ease of Use Questionnaire. It measures the subjective usability of a product or service. It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction. The questionnaires were constructed as seven-point Likert rating scales. Users were asked to rate agreement with the statements, ranging from strongly disagree (1) to strongly agree (7). | Day 1, Day 8 and Day 15 | |
Secondary | UTAUT (Unified theory of acceptance of technology) questionnaire | Questionnaire of acceptability / acceptance of the tool and its use by patients based on the Unified Theory of Acceptance and Use Technology (UTAUT). | Day 1, Day 8 and Day 15 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01589289 -
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
|
Phase 3 | |
Completed |
NCT00010881 -
Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
|
N/A | |
Recruiting |
NCT04461821 -
Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
|
||
Completed |
NCT04094571 -
Muscle Delay Characterization
|
N/A | |
Recruiting |
NCT02795052 -
Neurologic Stem Cell Treatment Study
|
N/A | |
Completed |
NCT02219269 -
A Complex Contraception Registry
|
N/A | |
Completed |
NCT00122174 -
Stress-Busting Program for Caregivers of Patients With Neruological Diseases
|
N/A | |
Recruiting |
NCT01524276 -
Product Surveillance Registry
|
||
Completed |
NCT00532571 -
Effects of Coenzyme Q10 in PSP and CBD
|
Phase 2/Phase 3 | |
Completed |
NCT05830981 -
Valproic Acid Use in Patients With Neurological Disorders
|
||
Completed |
NCT01754168 -
Amyloid Beta and Cognition in Parkinson Disease
|
N/A | |
Completed |
NCT02780531 -
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
|
||
Completed |
NCT01858350 -
Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation
|
N/A | |
Suspended |
NCT05212727 -
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
|
||
Recruiting |
NCT01266382 -
The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders
|
N/A |